These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity. Staibano S, Mignogna MD, Lo Muzio L, Di Alberti L, Di Natale E, Lucariello A, Mezza E, Bucci E, DeRosa G. Hum Pathol; 1998 Nov; 29(11):1189-94. PubMed ID: 9824094 [Abstract] [Full Text] [Related]
27. Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status. Moriki T, Takahashi T, Kataoka H, Hiroi M, Yamane T, Hara H. Pathol Int; 1996 Dec; 46(12):953-61. PubMed ID: 9110347 [Abstract] [Full Text] [Related]
32. Imbalance between proliferation and apoptosis may be responsible for treatment failure after postoperative radiotherapy in squamous cell carcinoma of the oropharynx. Grabenbauer GG, Suckorada O, Niedobitek G, Rödel F, Iro H, Sauer R, Rödel C, Schultze-Mosgau S, Distel L. Oral Oncol; 2003 Jul; 39(5):459-69. PubMed ID: 12747970 [Abstract] [Full Text] [Related]
33. Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma. Ikeguchi M, Saito H, Katano K, Tsujitani S, Maeta M, Kaibara N. J Am Coll Surg; 1997 Oct; 185(4):398-403. PubMed ID: 9328389 [Abstract] [Full Text] [Related]
35. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Girod SC, Pfeiffer P, Ries J, Pape HD. Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452 [Abstract] [Full Text] [Related]